{"transactions":[{"id":689380,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-12T21:07:48.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":39341,"price":12.97,"value":510252.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (the \"Shares\") sold to cover tax withholding obligations in connection with the vesting of the Reporting Person's performance-based restricted stock units (the \"PSUs\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreements under which the PSUs were granted and does not represent a discretionary sale by the Reporting Person."}],"balance_after":708151,"source":{"system":"sec-edgar","filing":"0001104659-26-095012","document":"tm2623037-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465926095012/tm2623037-4_4seq1.xml","form_type":"4"}},{"id":721378,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":2955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully vested."}],"balance_after":13000,"derivative":{"exercise_price":37.54,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":2955},"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721377,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":881,"price":192.6139,"value":169692.8459,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The transaction was executed in multiple trades in prices ranging from $192.55 to $192.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":21656,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721376,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":541,"price":191.8661,"value":103799.5601,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The transaction was executed in multiple trades in prices ranging from $191.47 to $192.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":22537,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721375,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":600,"price":190.545,"value":114327.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transaction was executed in multiple trades in prices ranging from $190.44 to $190.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":23078,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721374,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":100,"price":188.57,"value":18857.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":23678,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721373,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":300,"price":187.8267,"value":56348.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The transaction was executed in multiple trades in prices ranging from $187.46to $188.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":23778,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721372,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":858,"price":186.9157,"value":160373.6706,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades in prices ranging from $186.38 to $187.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":24078,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721371,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":185.8991,"value":204489.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $185.37 to $186.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":24936,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721370,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":900,"price":184.5869,"value":166128.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $184.08 to $184.98, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":26036,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721369,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":300,"price":183.1733,"value":54951.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $182.93 to $183.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":26936,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":721368,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T22:25:05.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":2955,"price":37.54,"value":110930.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,191 restricted stock units."}],"balance_after":27236,"source":{"system":"sec-edgar","filing":"0001610717-26-000311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000311/form4.xml","form_type":"4"}},{"id":729256,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:43:53.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":3127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 18, 2026 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":3127,"derivative":{"exercise_price":162.99,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":3127},"source":{"system":"sec-edgar","filing":"0001610717-26-000284","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000284/form4.xml","form_type":"4"}},{"id":729255,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-23T21:43:53.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Includes 1,191 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,191 restricted stock units."}],"balance_after":24281,"source":{"system":"sec-edgar","filing":"0001610717-26-000284","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071726000284/form4.xml","form_type":"4"}},{"id":770177,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:15:50.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":37324,"price":5.08,"value":189605.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (the \"Shares\") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $5.01 to $5.08 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range."}],"balance_after":747492,"source":{"system":"sec-edgar","filing":"0001104659-26-064519","document":"tm2615137-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465926064519/tm2615137-2_4seq1.xml","form_type":"4"}},{"id":813512,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-04-08T01:09:17.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":376860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2027, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":376860,"derivative":{"exercise_price":7.61,"expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":376860},"source":{"system":"sec-edgar","filing":"0001104659-26-040571","document":"tm2611350-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465926040571/tm2611350-11_4seq1.xml","form_type":"4"}},{"id":813511,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-08T01:09:17.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":251240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2027 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2030, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":784816,"source":{"system":"sec-edgar","filing":"0001104659-26-040571","document":"tm2611350-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465926040571/tm2611350-11_4seq1.xml","form_type":"4"}},{"id":962121,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:14:48.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 50% of the RSUs will vest on November 15, 2026 and 50% of the RSUs will vest on November 15, 2027, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":533576,"source":{"system":"sec-edgar","filing":"0001104659-25-123290","document":"tm2533977-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465925123290/tm2533977-5_4seq1.xml","form_type":"4"}},{"id":980414,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:30:14.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":11.13,"value":111300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 2, 2025, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.26. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 333,576 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 753,750 shares of the Issuer's common stock, 331,353 of which are exercisable as of the date hereof."}],"balance_after":333576,"source":{"system":"sec-edgar","filing":"0001104659-25-118483","document":"tm2532752-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465925118483/tm2532752-1_4seq1.xml","form_type":"4"}},{"id":1099372,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-30T20:27:19.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":11574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":11574,"derivative":{"exercise_price":37.48,"expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":11574},"source":{"system":"sec-edgar","filing":"0001610717-25-000272","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071725000272/form4.xml","form_type":"4"}},{"id":1099371,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-30T20:27:19.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":3142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Includes 4,017 Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,017 Restricted Stock Units."}],"balance_after":23090,"source":{"system":"sec-edgar","filing":"0001610717-25-000272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071725000272/form4.xml","form_type":"4"}},{"id":1137423,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-23T01:44:48.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":25105,"price":8.06,"value":202346.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (the \"Shares\") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $8.05 to $8.80 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range."}],"balance_after":343576,"source":{"system":"sec-edgar","filing":"0001104659-25-052143","document":"tm2515608-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465925052143/tm2515608-4_4seq1.xml","form_type":"4"}},{"id":1180024,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-04T00:06:13.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2026, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":8.4,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-25-031835","document":"tm2511407-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465925031835/tm2511407-11_4seq1.xml","form_type":"4"}},{"id":1180023,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-04T00:06:13.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":166667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2026 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2029, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":368681,"source":{"system":"sec-edgar","filing":"0001104659-25-031835","document":"tm2511407-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465925031835/tm2511407-11_4seq1.xml","form_type":"4"}},{"id":1326859,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-19T02:00:13.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":12.42,"value":124200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on April 3, 2024, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 to $12.62. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 202,014 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 513,750 shares of the Issuer's common stock, 189,478 of which are exercisable as of the date hereof."}],"balance_after":202014,"source":{"system":"sec-edgar","filing":"0001104659-24-129864","document":"tm2431484-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465924129864/tm2431484-1_4seq1.xml","form_type":"4"}},{"id":1377238,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-04T21:05:32.000Z","date":"2024-10-31","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023."}],"balance_after":13400,"derivative":{"exercise_price":24.84,"exercise_date":"2024-06-08","expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001610717-24-000516","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000516/form4.xml","form_type":"4"}},{"id":1377237,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-04T21:05:32.000Z","date":"2024-10-31","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":54.1429,"value":270714.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $54.00 to $54.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,748 restricted stock units."}],"balance_after":19948,"source":{"system":"sec-edgar","filing":"0001610717-24-000516","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000516/form4.xml","form_type":"4"}},{"id":1377236,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-04T21:05:32.000Z","date":"2024-10-31","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":24.84,"value":124200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,748 restricted stock units."}],"balance_after":24948,"source":{"system":"sec-edgar","filing":"0001610717-24-000516","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000516/form4.xml","form_type":"4"}},{"id":1456989,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-10T20:36:12.000Z","date":"2024-07-09","kind":"exercise","planned":true,"acquired":false,"shares":2155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":32490,"derivative":{"exercise_price":16.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":2155},"source":{"system":"sec-edgar","filing":"0001610717-24-000394","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000394/form4.xml","form_type":"4"}},{"id":1456988,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-10T20:36:12.000Z","date":"2024-07-09","kind":"sale","planned":true,"acquired":false,"shares":2155,"price":44,"value":94820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,623 restricted stock units."}],"balance_after":19948,"source":{"system":"sec-edgar","filing":"0001610717-24-000394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000394/form4.xml","form_type":"4"}},{"id":1456987,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-10T20:36:12.000Z","date":"2024-07-09","kind":"exercise","planned":true,"acquired":true,"shares":2155,"price":16.8,"value":36204.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,623 restricted stock units."}],"balance_after":22103,"source":{"system":"sec-edgar","filing":"0001610717-24-000394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000394/form4.xml","form_type":"4"}},{"id":1467332,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T21:06:12.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":15955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date."}],"balance_after":15955,"derivative":{"exercise_price":37.54,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":15955},"source":{"system":"sec-edgar","filing":"0001610717-24-000374","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000374/form4.xml","form_type":"4/A","original_submission_date":"2024-06-24"}},{"id":1467331,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-28T21:06:12.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 8,623 restricted stock units (\"RSUs\")."}],"balance_after":19948,"source":{"system":"sec-edgar","filing":"0001610717-24-000374","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000374/form4.xml","form_type":"4/A","original_submission_date":"2024-06-24"}},{"id":1470802,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T20:22:26.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":16700,"derivative":{"exercise_price":37.54,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001610717-24-000361","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000361/form4.xml","form_type":"4"}},{"id":1470801,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-24T20:22:26.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,175 Restricted Stock Units."}],"balance_after":20500,"source":{"system":"sec-edgar","filing":"0001610717-24-000361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000361/form4.xml","form_type":"4"}},{"id":1509131,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-21T00:01:55.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":20194,"price":6.47,"value":130655.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (the \"Shares\") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $6.46 to $6.56 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range."}],"balance_after":212014,"source":{"system":"sec-edgar","filing":"0001104659-24-063559","document":"tm2414961-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465924063559/tm2414961-2_4seq1.xml","form_type":"4"}},{"id":1542641,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-12T20:23:40.000Z","date":"2024-04-10","kind":"exercise","planned":true,"acquired":false,"shares":2155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":34645,"derivative":{"exercise_price":16.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":2155},"source":{"system":"sec-edgar","filing":"0001610717-24-000205","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000205/form4.xml","form_type":"4"}},{"id":1542640,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-12T20:23:40.000Z","date":"2024-04-10","kind":"sale","planned":true,"acquired":false,"shares":2155,"price":37,"value":79735.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,450 restricted stock units."}],"balance_after":15700,"source":{"system":"sec-edgar","filing":"0001610717-24-000205","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000205/form4.xml","form_type":"4"}},{"id":1542639,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-12T20:23:40.000Z","date":"2024-04-10","kind":"exercise","planned":true,"acquired":true,"shares":2155,"price":16.8,"value":36204.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,450 restricted stock units."}],"balance_after":17855,"source":{"system":"sec-edgar","filing":"0001610717-24-000205","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071724000205/form4.xml","form_type":"4"}},{"id":1550191,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-04-04T00:03:55.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2025, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":7.73,"expiration_date":"2034-04-01","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-24-043258","document":"tm2410652-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465924043258/tm2410652-11_4seq1.xml","form_type":"4"}},{"id":1550190,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-04T00:03:55.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":83335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2025 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2028, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":232208,"source":{"system":"sec-edgar","filing":"0001104659-24-043258","document":"tm2410652-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465924043258/tm2410652-11_4seq1.xml","form_type":"4"}},{"id":1854626,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2023-06-16T01:00:33.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":553,"price":23.44,"value":12962.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.29 to $23.53. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this form 4, the reporting person continues to beneficially own 148,873 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 263,750 shares of the Issuer's common stock, 88,072 of which are exercisable as of the date hereof."}],"balance_after":148873,"source":{"system":"sec-edgar","filing":"0001104659-23-071772","document":"tm2318878-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465923071772/tm2318878-1_4seq1.xml","form_type":"4"}},{"id":1854625,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2023-06-16T01:00:33.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":5145,"price":24.11,"value":124045.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.80 to $24.54. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":149426,"source":{"system":"sec-edgar","filing":"0001104659-23-071772","document":"tm2318878-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465923071772/tm2318878-1_4seq1.xml","form_type":"4"}},{"id":1859038,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:14:21.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 8, 2023 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":18400,"derivative":{"exercise_price":24.84,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001610717-23-000131","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071723000131/form4.xml","form_type":"4"}},{"id":1859037,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-12T20:14:21.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 13,950 Restricted Stock Units."}],"balance_after":15700,"source":{"system":"sec-edgar","filing":"0001610717-23-000131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000161071723000131/form4.xml","form_type":"4"}},{"id":1887028,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2023-05-19T00:36:09.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":15575,"price":18.05,"value":281128.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05 to $18.23. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":154571,"source":{"system":"sec-edgar","filing":"0001104659-23-062378","document":"tm2316199-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465923062378/tm2316199-9_4seq1.xml","form_type":"4"}},{"id":1928851,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-05T00:01:02.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":17.66,"expiration_date":"2033-04-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-23-041719","document":"tm2311410-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465923041719/tm2311410-3_4seq1.xml","form_type":"4"}},{"id":1928850,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:01:02.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":170146,"source":{"system":"sec-edgar","filing":"0001104659-23-041719","document":"tm2311410-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465923041719/tm2311410-3_4seq1.xml","form_type":"4"}},{"id":2228303,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T21:06:31.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":36800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":36800,"derivative":{"exercise_price":16.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":36800},"source":{"system":"sec-edgar","filing":"0001567619-22-013113","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000156761922013113/doc1.xml","form_type":"4"}},{"id":2228302,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T21:06:31.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,500 Restricted Stock Units."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001567619-22-013113","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000156761922013113/doc1.xml","form_type":"4"}},{"id":2265951,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-05-18T23:01:55.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":10687,"price":14.59,"value":155923.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.59 to $14.62. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":130146,"source":{"system":"sec-edgar","filing":"0001104659-22-062607","document":"tm2215879-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465922062607/tm2215879-4_4seq1.xml","form_type":"4"}},{"id":2304955,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-05T20:16:27.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":78750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":78750,"derivative":{"exercise_price":18.26,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":78750},"source":{"system":"sec-edgar","filing":"0001104659-22-042768","document":"tm2211665-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465922042768/tm2211665-4_4seq1.xml","form_type":"4"}},{"id":2304954,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T20:16:27.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":140833,"source":{"system":"sec-edgar","filing":"0001104659-22-042768","document":"tm2211665-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465922042768/tm2211665-4_4seq1.xml","form_type":"4"}},{"id":2727637,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-06T01:02:03.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on May 3, 2022, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":125000,"derivative":{"exercise_price":36.75,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-21-061913","document":"tm2115244-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465921061913/tm2115244-2_4seq1.xml","form_type":"4"}},{"id":2727636,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":24169,"kind":"person","name":"Patel Sushil","position":1,"cik":"0001860609","reported_name":"Patel Sushil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-06T01:02:03.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":88333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2022 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2025, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":88333,"source":{"system":"sec-edgar","filing":"0001104659-21-061913","document":"tm2115244-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860609/000110465921061913/tm2115244-2_4seq1.xml","form_type":"4"}}]}